Free Trial
NASDAQ:QNTM

Quantum Biopharma (QNTM) Stock Price, News & Analysis

Quantum Biopharma logo
$8.18 +0.14 (+1.74%)
As of 01:57 PM Eastern

About Quantum Biopharma Stock (NASDAQ:QNTM)

Key Stats

Today's Range
$7.50
$8.36
50-Day Range
$2.91
$14.50
52-Week Range
$2.70
$18.00
Volume
174,245 shs
Average Volume
1.19 million shs
Market Capitalization
$15.70 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Quantum Biopharma Ltd. is a biotechnology pharmaceutical research and development company, which focuses on the cultivation, process, and sale of medical cannabis. It operates through the Biotechnology and Strategic Investments segments. The Biotechnology segment is involved in the research and development of the company's three drug candidates consisting of FSD-PEA, Lucid-PSYCH, and Lucid-MS. The Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial property. The company was founded by Thomas Fairfull, Zeeshan Saeed and Anthony J. Durkacz on October 20, 1994 and is headquartered in Toronto, Canada.

Remove Ads
Receive QNTM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Quantum Biopharma and its competitors with MarketBeat's FREE daily newsletter.

QNTM Stock News Headlines

Best Cannabis Stocks To Watch Now - March 30th
New “Trump” currency proposed in DC
According to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America.
Top Cannabis Stocks To Follow Today - March 28th
Cannabis Stocks To Follow Today - March 29th
Quantum BioPharma reports progress in drug trials
See More Headlines

QNTM Stock Analysis - Frequently Asked Questions

Quantum Biopharma's stock was trading at $3.68 on January 1st, 2025. Since then, QNTM shares have increased by 119.3% and is now trading at $8.07.
View the best growth stocks for 2025 here
.

Quantum Biopharma Ltd. (NASDAQ:QNTM) issued its earnings results on Friday, March, 28th. The company reported ($2.89) EPS for the quarter, missing analysts' consensus estimates of ($0.80) by $2.09.

Shares of QNTM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Quantum Biopharma investors own include Jiuzi (JZXN), Aethlon Medical (AEMD), Aditxt (ADTX), Adial Pharmaceuticals (ADIL), Avalon GloboCare (ALBT), Ainos (AIMD) and AMC Entertainment (AMC).

Company Calendar

Last Earnings
3/28/2025
Today
4/03/2025
Next Earnings (Estimated)
5/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:QNTM
Previous Symbol
NASDAQ:QNTM
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-17,900,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$21.29 per share
Price / Book
0.38

Miscellaneous

Free Float
1,755,000
Market Cap
$15.49 million
Optionable
N/A
Beta
0.37
10 Stocks Set to Soar in Spring 2025 Cover

Market volatility creates opportunity. Our analysts have pinpointed 10 stocks perfectly positioned for exceptional growth this spring, even amid economic uncertainty. Don't miss your chance to access this timely research and invest with confidence.

Get This Free Report

This page (NASDAQ:QNTM) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners